Ivermectin and Mebendazole in Cancer Treatment

84% of ca- cancer patients taking a combination of

ivermectin and mebendazole for six months

declared their cancer was either completely gone,

regressed, or had stopped spreading.

Largest human, uh, observational study on ivermectin,

mebendazole in cancer.

We had like 200 cancer patients, and what we found was after six months,

84.4% of them reported to have benefited in their cancer treatments.

About half, either their cancers disappeared,

they had no evidence of disease,

or their tumors shrank. And again, that is half of this entire cohort.

Tell me what this says.

After the six months of taking the ivermectin and mebendazole,

32.8% declared that their cancers

disappeared. They had what's called no evidence of

disease.

15.6% reported that their tumors were

shrinking. It's called regression.

And then 36% said their cancers were not progressing.

So that's called cancer stabilization.

And that makes up the 84.4% clinical

benefit ratio. In other words, 84.4% of the

cancer patients who took ivermectin and mebendazole

benefited in their cancer treatment